Oncomax Acquisition Corporation is categorized under Noncommercial Biotechnical Research in La Jolla, CA and active since 2005.
Oncomax Acquisition Corporation was established in 2005, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Noncommercial Biotechnical Research business, which does work in the B2B market, and is classified as a Noncommercial Biotechnical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Krisztina Zsebo at the company’s single location by writing to 2223 Avenida De La Playa, La Jolla, California CA 92037 or by phoning (858) 366-4081. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Oncomax Acquisition Corporation |
Contact Person: | Krisztina Zsebo |
Address: | 2223 Avenida De La Playa, La Jolla, California 92037 |
Phone Number: | (858) 366-4081 |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 2005 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Noncommercial Biotechnical Research |
SIC Code: | 8733 |
NAICS Code: | 541720 |
Share This Business: |
Oncomax Acquisition Corporation was started in 2005 to provide professional Noncommercial Biotechnical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Krisztina Zsebo for inquiries that concern Oncomax Acquisition Corporation by calling the company number (858) 366-4081, as your correspondence is most welcome. Additionally, the physical location of the single location of Oncomax Acquisition Corporation can be found at the coordinates 32.853717,-117.255261 as well as the street address 2223 Avenida De La Playa in La Jolla, California 92037.
For its online presence, you may visit Oncomax Acquisition Corporation’s website at and engage with its social media outlets through on Twitter and on Facebook.